# A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

> **NCT01675531** · PHASE4 · COMPLETED · sponsor: **Mundipharma Korea Ltd** · enrollment: 73 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Targin

## Key facts

- **NCT ID:** NCT01675531
- **Lead sponsor:** Mundipharma Korea Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2016-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675531, "A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01675531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*